DecisionDx®-SCC Scientific References

DecisionDx®-SCC Clinical Evidence

Wysong A, Newman JG, Covington KR, et al. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2020. doi:

Ibrahim SF, Kasprzak J, Hall MA, et al. Improved cutaneous squamous cell carcinoma metastasis risk assessment, submitted.

Data on file, Castle Biosciences.

DecisionDx-SCC Clinical Impact Studies and Surveys

Farberg AS, Hall MA, Douglas L, et al. Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: Impact on patient management. Curr Med Res Opin 2020. doi:10.1080/03007995.2020.1763284

Litchman GH, Fitzgerald AL, Kurley SJ, et al. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma. Curr Med Res Opin 2020. doi:10.1080/03007995.2020.1763283

Teplitz R, Prado G, Litchman GB, Rigel DS. Impact of gene expression profile testing on the management of squamous cell carcinoma by dermatologistsJ Drugs Dermatol 2019;18:980-4.

Squamous Cell Carcinoma and Melanoma Information

SEER data release 2019.

Mansouri B, Housewright CD. The treatment of actinic keratoses— the rule rather than the exception. JAMA Dermatol 2017;153:1200.


Order DecisionDx-SCC

For Information

Call: 866-788-9007

What's Next?

DecisionDx®-UM Overview

How Do You Get a
DecisionDx-SCC Test?

Scroll to Top